These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 12442391)

  • 1. [Immunohistochemical observation of Fas in the liver of chronic hepatitis B and its ultrastructural localization].
    Takatani M; Yamada G
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):234-40. PubMed ID: 12442391
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunohistochemical observation of Fas in the liver with chronic hepatitis C].
    Takatani M; Yamada G
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):667-74. PubMed ID: 7563854
    [No Abstract]   [Full Text] [Related]  

  • 3. The concentration of Fas in the serum and liver tissue in viral chronic hepatitis B patients treated with lamivudine.
    Lapinski TW
    Hepatogastroenterology; 2005; 52(62):575-9. PubMed ID: 15816481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fas antigen expression and apoptosis in liver tissues of patients with chronic hepatitis B].
    Mochizuki K; Hayashi N; Hiramatsu N; Kamada T
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):228-33. PubMed ID: 12442390
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of Fas antigen on hepatocytes in viral hepatitis patients.
    Sekine K; Nishimaki T; Suzuki T; Kasukawa R
    Fukushima J Med Sci; 1997 Jun; 43(1):51-9. PubMed ID: 9431784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C.
    Hiramatsu N; Hayashi N; Katayama K; Mochizuki K; Kawanishi Y; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1994 Jun; 19(6):1354-9. PubMed ID: 7514559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
    Bortolami M; Kotsafti A; Cardin R; Farinati F
    J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
    El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
    APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical detection of Fas and apoptosis in type-1 autoimmune hepatitis.
    Seki S; Kitada T; Iwai S; Kadoya H; Yamada T; Kawada N; Sakaguchi H; Wakasa K
    Hepatogastroenterology; 2003; 50(53):1274-7. PubMed ID: 14571717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic analysis in chronic hepatitis B patients: a retrospective study of 216 cases about Scheuer scores, in situ expression of viral antigens and tissue hepatitis B virus DNA levels.
    Zhu R; Huang H; Zhang H; Wang Z; Hu X; Zhai W; Lin Y; Wang J; Zhu H
    Liver Int; 2006 Feb; 26(1):82-9. PubMed ID: 16420513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
    Ramakrishna B; Mukhopadhya A; Kurian G
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic hepatitis B and hepatocarcinogenesis: does prevention of "collateral damage" bring the cure?
    Manigold T; Rehermann B
    Hepatology; 2003 Mar; 37(3):707-10. PubMed ID: 12627596
    [No Abstract]   [Full Text] [Related]  

  • 14. Morphological lesions detected by light and electron microscopies in chronic type B hepatitis.
    Kasprzak A; Biczysko W; Adamek A; Zabel M
    Pol J Pathol; 2002; 53(3):103-15. PubMed ID: 12476611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical study of Fas ligand in liver tissue of chronic hepatitis B virus infection].
    Hu J; Zhang L; Wang H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):64-6. PubMed ID: 12515176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas-mediated apoptosis of hepatic cells.
    Feldmann G; Lamboley C; Moreau A; Bringuier A
    Biomed Pharmacother; 1998; 52(9):378-85. PubMed ID: 9856284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The localization of FasL mRNA in liver tissues of chronic hepatitis B].
    Hu J; Zhang L; Zhao J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Dec; 12(4):316-7. PubMed ID: 12526342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis in acute hepatic failure: histopathological study of human liver tissue using the tunel method and immunohistochemistry.
    Kasahara I; Saitoh K; Nakamura K
    J Med Dent Sci; 2000 Sep; 47(3):167-75. PubMed ID: 12160229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Fas ligand by hepatic macrophages in patients with fulminant hepatic failure.
    Mita A; Hashikura Y; Tagawa Y; Nakayama J; Kawakubo M; Miyagawa S
    Am J Gastroenterol; 2005 Nov; 100(11):2551-9. PubMed ID: 16279913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study.
    Tsamandas AC; Thomopoulos K; Zolota V; Kourelis T; Karatzas T; Ravazoula P; Tepetes K; Petsas T; Karavias D; Karatza C; Bonikos DS; Gogos C
    Mod Pathol; 2003 Dec; 16(12):1273-88. PubMed ID: 14681329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.